Research
Researchers in the Spotlight
Calming a Storm in the Immune System
Dr. Michael Jordan developed the perforin-deficient animal model that is helping advance the study of better treatments for HLH. He is now leading a multicenter clinical trial testing a new approach for treating HLH.
Published Research
- Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment.
- Hemophagocytic lymphohistiocytosis: updates and evolving concepts.
- The expanding spectrum of hemophagocytic lymphohistiocytosis.
- Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis
- Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis
- Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders
- Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency